EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparing cost of F(.ab’)2AV vs FabAV in the treatment of copperhead envenomation–One center's experience

Jason B Hack, Kori L Brewer, William J Meggs

The American Journal of Emergency Medicine · 2023

DOI: 10.1016/j.ajem.2023.08.010 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The American Journal of Emergency Medicine, 2023. Verfasst von Jason B Hack und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Toxicology, United States of America; Department of Emergency Medicine, East Carolina University, Greenville, NC 27858, United St…. Hauptthemen laut MEDLINE: Antivenins, Snake Bites, Immunoglobulin Fab Fragments, Agkistrodon. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The definitive treatment of North American crotalid snakebites is antivenin. In 2000, an FabAV antivenom (CroFab®) was introduced and in 2022, F(ab')2AV (Anavip®) was approved for treatment of copperhead bites. Our center that sees primarily copperhead snake bites added the recently approved treatment as a second option for the 2022 snake bite season. This brief report we describe our initial experience with the two antivenins via retrospective chart review: the cost, charge, laboratory differences, response to therapy, complications and duration of hospitalization of admitted patients with copperhead envenomation. Using three independent reviewers in this IRB exempt report we found 31 patients with copperhead bites (7 exclusions) leaving 19 adults and 7 children for analysis. We found there was no difference in age, sex, presence of lab abnormalities, total vials administered, or length of stay. There was significant differences in hospital costs and charges to the patient. Future research should include multi-center experiences comparing the two antivenins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiveninsSnake BitesImmunoglobulin Fab FragmentsAgkistrodonHumansRetrospective StudiesMaleFemaleAnimalsAdultChildImmunoglobulin FragmentsMiddle AgedLength of StayAdolescentChild, PreschoolCrotalid VenomsYoung Adult

Stichwörter der Autor:innen

AntivenomCopperheadMedical costSnakebites

Substanzen

AntiveninsCrotalidae Polyvalent immune FabImmunoglobulin Fab FragmentsImmunoglobulin FragmentsCrotalid Venoms

Autor:innen und Institutionen

  • Division of Medical Toxicology, United States of America; Department of Emergency Medicine, East Carolina University, Greenville, NC 27858, United States of America. Electronic address: Hackj20@ecu.edu.
  • Department of Emergency Medicine, East Carolina University, Greenville, NC 27858, United States of America.

Zitieren

APA

Hack, J. B., Brewer, K. L., & Meggs, W. J. (2023). Comparing cost of F(.ab’)2AV vs FabAV in the treatment of copperhead envenomation–One center's experience. The American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2023.08.010

Vancouver

Hack JB, Brewer KL, Meggs WJ. Comparing cost of F(.ab’)2AV vs FabAV in the treatment of copperhead envenomation–One center's experience. The American Journal of Emergency Medicine. 2023. doi:10.1016/j.ajem.2023.08.010

BibTeX
@article{Hack2023,
  author = {Hack, Jason B and Brewer, Kori L and Meggs, William J},
  title = {Comparing cost of F(.ab’)2AV vs FabAV in the treatment of copperhead envenomation–One center's experience},
  journal = {The American Journal of Emergency Medicine},
  year = {2023},
  doi = {10.1016/j.ajem.2023.08.010}
}
Kostenlos starten →